REMEGEN (09995): Purchase financial products

date
20:25 18/08/2026
avatar
GMT Eight
Rongchang Biological (09995) announced that on August 18, 2026, the company further entered into Agreement No. 2 for OCBC Financial Products with OCBC Bank, under which the company agrees to use $30 million of its idle funds to purchase financial products from OCBC Bank.
REMEGEN (09995) announced that on August 18, 2026, the company further entered into Agreement No. 2 for the financial products with OCBC Bank, pursuant to which the company agrees to use USD 30 million of its idle own funds to purchase financial products from OCBC Bank.